Spero Therapeutics (SPRO) EBIT Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 32.96% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -29.67% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -50.81% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 13.47% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 16.35% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -12.10% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 55.96% |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 19.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.08% |
| Dec 31, 2025 | 5.47% |
| Sep 30, 2025 | 12.15% |
| Jun 30, 2025 | 54.58% |
| Mar 31, 2025 | 21.29% |
| Dec 31, 2024 | 2.62% |
| Sep 30, 2024 | 6.19% |
| Jun 30, 2024 | -0.92% |
| Mar 31, 2024 | 10.35% |
| Dec 31, 2023 | 69.82% |
| Sep 30, 2023 | 53.33% |
| Jun 30, 2023 | 11.31% |
| Mar 31, 2023 | 14.57% |
| Dec 31, 2022 | 44.77% |
| Sep 30, 2022 | 13.41% |
| Jun 30, 2022 | -24.08% |
| Mar 31, 2022 | -74.39% |
| Dec 31, 2021 | -35.38% |
| Sep 30, 2021 | -27.24% |
| Jun 30, 2021 | -22.97% |
| Mar 31, 2021 | -21.51% |
| Dec 31, 2020 | -10.32% |
| Sep 30, 2020 | -24.04% |
| Jun 30, 2020 | -22.04% |
| Mar 31, 2020 | -44.28% |
| Dec 31, 2019 | -43.22% |
| Sep 30, 2019 | -31.47% |